New Issue: Science’s Impossible Questions. Read Now

30 under 30: Battling Disease with Nanoparticles

Meet Sandra García-Gallego, one of the promising young chemists attending the 2013 Lindau Nobel Laureate Meeting

Join Our Community of Science Lovers!

Each year hundreds of the best and brightest researchers gather in Lindau, Germany, for the Nobel Laureate Meeting. There, the newest generation of scientists mingles with Nobel Prize winners and discusses their work and ideas. The 2013 meeting is dedicated to chemistry and will involve young researchers from 78 different countries. In anticipation of the event, which will take place from June 30 through July 5, we are highlighting a group of attendees under 30 who represent the future of chemistry. The following profile is the 25th in a series of 30.

Name: Sandra García-Gallego
Age: 27
Born: Guadalajara, Spain
Nationality: Spanish

Current position: Staff researcher at the University of Alcalá in Spain
Education: Bachelor's degree in chemistry with a specialization in medical chemistry and a Master's degree in therapeutic targets: research and development, both from the University of Alcalá; Master's degree in teacher training in obligatory and upper secondary school education from the National University of Distance Education in Spain; PhD from the University of Alcalá


On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


What is your field of research?
My main interest lies in the development of nanoparticles called dendrimers as tools for treating different diseases such as HIV infection, cancer and immunological diseases.

What drew you to chemistry, and to that research area in particular?
I have always been attracted to synthetic chemistry because you can design an infinite world of molecules for different purposes piece by piece. In my case, those molecules are focused on biomedical applications. This is why I am pursuing a multidisciplinary PhD project that combines chemistry and biochemistry.

Where do you see yourself in 10 years?
I aim to continue my research career at the intersection of chemistry and biology by designing different nanoparticles for diverse biomedical applications. It's not easy for me to choose only one puzzle to solve!

Who are your scientific heroes?
My scientific heroes are those young researchers who are expending great effort every day and are waiting for their opportunity to be recognized. I think that most researchers could be commended for some aspect of their lives.

What activities outside of chemistry do you most enjoy?
In my leisure time I have an interest in puzzle-solving and reading books—not so different from what I do inside the lab!

What do you hope to gain from this year's Lindau meeting?
According to Lindau's slogan of "educating, inspiring and connecting scientific generations," I think, in both professional and personal areas, this is a great opportunity. I will be learning from Nobel laureates but also from young students with fresh ideas who are eager to share and improve their knowledge.

Are there any Nobelists whom you are particularly excited to meet?
It's difficult to mention just one of them, but I have a special personal and professional interest in meeting Professor Robert Grubbs because of his advances in organic synthesis. I'm also looking forward to learn Professor Aaron Ciechanover's opinion about drug development in the 21st century.

« Previous 24. Tomasz Kaminski

30 Under 30: Lindau Nobel Laureate Meeting

Next » 26. Loïc Stefan

Subscribe to Support Independent Journalism

Great science journalism requires human expertise, time, effort and creativity. And it costs money. That’s why I and the journalists here at Scientific American hope you’ll join our community.

When you subscribe, you are supporting staff and freelance journalists who are passionate about telling science stories that are true, important and compelling. Our editors and reporters are often experts in their fields, which means they understand the nuances of big discoveries and can untangle the breakthroughs from the hype. With a subscription, you are also supporting rigorous fact-checking to ensure the words we publish are precise and accurate. And you’re supporting original illustrations, graphics and photos that bring you closer to an advanced laboratory, an ice sheet in Antarctica or a space mission in orbit. You’re helping us craft other types of high-quality journalism as well: Our newsletters are carefully written, edited and curated by staffers you have or will come to know and love. Our Science Quickly podcast is based on original reporting, collaboration with editors and scientists and exacting production.

Subscriptions keep this engine running so we can continue to deliver thoughtful, rigorous and independent science journalism to you. In an era of viral misinformation, this work is crucial. If you value what we do, I hope you’ll consider joining us as a subscriber

Thank you,

Jeanna Bryner, Editor in Chief, Scientific American

Subscribe